Clinical Usefulness of Angiotensin Converting Enzyme Inhibitor and its Effects on Lipidolysis and Glycometabolism
| Autor: | Saeko Anjo, Satoko Ishida, Shigeo Yamamura, Atsushi Namiki, Chie Kiryu, Masahiko Obayashi, Sumiko Matsuda |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
chemistry.chemical_classification
medicine.medical_specialty biology Triglyceride business.industry nutritional and metabolic diseases Blood sugar Angiotensin-converting enzyme medicine.disease chemistry.chemical_compound Endocrinology Enzyme chemistry Internal medicine Diabetes mellitus Hyperlipidemia biology.protein medicine ANTILIPEMIC AGENTS In patient business |
| Zdroj: | Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29:750-755 |
| ISSN: | 1882-1499 1346-342X |
| Popis: | In this paper we present the effects of angiotensin-converting enzyme (ACE) inhibitors on the total cholesterol (TC) and triglyceride (TG) levels in the serum, and the blood sugar (BS) levels in patients with slight to mild hyperlipidemia and diabetes. One hundred three outpatients treated with ACE inhibitors were examined retrospectively. ACE inhibitors significantly decreased the TC, TG, and BS levels in hypertensive patients with slight hyperlipidemia or diabetes mellitus but who were not on medication. In hypertensive patients with mild hyperlipidemia treated with antilipemic agents, the ACE inhibitors did not decrease the TC and TG levels. In hypertensive patients with mild diabetes mellitus treated with antidiabetic agents, the ACE inhibitors also did not decrease the BS levels. These results show the decreasing effect of ACE inhibitors on the TC, TG and BS levels in patients with slight hyperlipidemia and diabetes mellitus in whom medication is not necessary. ACEinhibitors, therefore, have clinical usefulness of metabolizing the lipid and glucose in the serum, as well as acting as antihypertensive agents. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|